Delivery Order SPE2DB20D2014-SPE2DB24FB56E

Award Date 4/9/24
Potential Completion Date 4/10/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Eliquis 5 mg tablets. The contract has a potential value of $5,872.82 and a completion date of March 7, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. AmerisourceBergen Drug Corp also holds an indefinite...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablets. The $7,295.22 contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA, which serves as the primary vehicle for the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Eliquis 5 mg tablets. The $27,143.18 contract has a period of performance through March 21, 2024. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, which serves as the primary vehicle for the company to provide pharmaceuticals and...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $37,550.10 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product Eliquis 5 mg tablets. This delivery order was issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,119.95 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of Eliquis 5 mg tablets and has a performance period through March 13, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which was not set aside under any socioeconomic programs. Additionally, AmerisourceBergen Drug Corp holds an Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablets. The $17,336.55 firm fixed-price contract has a completion date of July 21, 2022. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablets. The $15,265.43 firm fixed-price contract has an ultimate completion date of April 17, 2024. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Eliquis 5 mg tablets. The contract has a firm fixed price of $14,704.21 and a performance period through April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablet 60s. The contract has a completion date of March 7, 2024 and a potential value of $2,456.02. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any type of small business. The company also holds an Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Eliquis 2.5 mg tablets for a total ceiling value of $1,583.40. The contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation. This delivery order is part of a larger single-award indefinite delivery contract...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB56E
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Eliquis 5 mg tablets. The $14,273.04 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to support Department of Defense medical treatment programs and facilities worldwide.

Generated 7/9/24, 1:25 PM